Companies: 10,795·Total market cap: $144.5T
Ardent Health Partners, LLC

Ardent Health Partners, LLC

ARDTNYSEHealthcare● Active
$8.61
$-0.08(-0.86%)
Market Cap$1.2B
P/E Ratio
52W High$15.48
52W Low$7.71

Ardent Health Partners, LLC (ARDT) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ardt · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
3
Sell
1
Strong Sell
0
Total: 12 · Buy rate: 66.7%

12-Month Price Target

High

$14.00

Consensus

$13.00

+57.0% upside

Low

$12.00

Median: $13 · Last Close: $8.28

The Ardent Health Partners, LLC (ARDT) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month ARDT price target is $13.00, representing +57.0% upside from the current price of $8.28.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $13 (57.0%)

Consensus Target

$13.00

57.0% upside

High Target

$14

69.1%

Low Target

$12

44.9%

Current Price

$8.28

as of today

Based on analyst price targets, the ARDT stock price prediction for the next 12 months ranges from $12 to $14. The consensus ARDT price forecast of $13.00 implies 57.0% upside from the current price of $8.28.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$7.875.00%

1-day model range: $7.8–$7.93. Peak: $7.93 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$9+10.4%
2028$10+16.7%
2029$10+20.4%
2030$10+22.5%
2031+23.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%
1Buy
0Neutral
13Sell
RSI (14)27.6Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ARDT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$8.53SELL
MA 10$8.93SELL
MA 20$9.37SELL
MA 50$9.44SELL
MA 100$9.22SELL
MA 200$10.49SELL
Current $ARDT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$8.57SELL
EMA 10$8.84SELL
EMA 20$9.15SELL
EMA 50$9.35SELL
EMA 100$9.55SELL
EMA 200$10.42SELL
Current $ARDT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-05-07
Maintains
BuyBuy
RBC Capital2026-03-10
Maintains
OutperformOutperform
Leerink Partners2026-03-06
Maintains
OutperformOutperform
JP Morgan2026-01-20
Maintains
NeutralNeutral
UBS2025-12-18
Maintains
BuyBuy
Mizuho2025-12-18
Maintains
OutperformOutperform
JP Morgan2025-11-24
Maintains
NeutralNeutral
Guggenheim2025-11-18
Maintains
BuyBuy
Mizuho2025-11-18
Maintains
OutperformOutperform
Keybanc2025-11-17
Downgrade ↓
OverweightSector Weight

Wall Street analysts have recently issued updated ratings on Ardent Health Partners, LLC (ARDT) stock. Of the recent 35 rating actions, 0 were upgrades and 4 were downgrades. 12 analysts currently cover ARDT.

Analyst Recommendation Trends

Buy ratings11
Hold ratings101
Sell ratings00

ARDT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$5.8B

↓ 11.0% YoY

Revenue Next Year

$6.4B

↑ 8.8% YoY

EPS This Year

$1.21

EPS Next Year

$1.05

↓ 13.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ARDT EPS of $1.21 for the current fiscal year, based on estimates from 6 analysts. The ARDT revenue forecast is $5.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ARDT stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ARDT price target is $13.00 (+57.0% upside), with an analyst consensus of Buy.

The ARDT short-term stock prediction for tomorrow is $7.87 (-5.00%). The ARDT stock price prediction for 2027 estimates an average of $9. The ARDT stock prediction for 2030 projects a range of $9–$11.

Ardent Health Partners, LLC trades on NYSE under the ticker ARDT. The ARDT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ARDT forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month ARDT price target is $13.00, with a high forecast of $14.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +57.0% potential upside from the current price of $8.28.

ARDT price targetWhat is ARDT price targetARDT analyst price targetARDT 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.